Remedy Meds Review 2026: Pricing, FDA Warning Letter & Alternatives
Remedy Meds emphasizes unlimited clinician access, monthly plan review and pharmacy fulfillment of compounded GLP-1 treatment if prescribed. Its homepage also lists branded options and advertises shipping within 48 hours. The current public pages reviewed October 28 did not establish a product-specific dollar quote, so this review focuses on the verified billing structure, care bundle and September 2025 FDA marketing letter.
What Is Remedy Meds & How Does It Operate?
The current Remedy billing guide says the initial payment secures consultation and assessment, then billing renews automatically every 28 days. A refill form is required before each shipment. Its help center says the base subscription amount includes medication, unlimited clinician visits and necessary lab work and does not rise with dose. Cancel-anytime service does not mean a processed payment is automatically refundable.
Remedy’s homepage advertises brand-name Ozempic and Zepbound alongside compounded semaglutide and tirzepatide. Read compounded semaglutide guide for the product distinctions.
The September 2025 FDA Warning Letter, Explained
The FDA’s September 9, 2025 letter cited website claims that implied compounded semaglutide and tirzepatide were the same as FDA-approved products. The agency identified misleading labeling/promotion and resulting misbranding. That is a documented marketing enforcement issue, not a laboratory finding about every product dispensed.
For a patient, the practical distinction is accurate product communication: a compounded prescription is not an FDA-approved branded product. The dated letter does not establish current resolution or every present practice, so this review does not claim either a close-out or ongoing violations beyond the letter. Read the FDA's GLP-1 compounding crackdown for broader regulatory context.
Remedy Meds Pricing vs the Market
Remedy’s help center specifies a 28-day cycle. Thirteen such cycles cover 364 days, so a recurring 28-day quote should not be compared with twelve calendar-month charges without adjusting the period. Its current public dollar price was not verified here. SurpassMD supplies the stated alternative price reference: semaglutide as low as $114/month and tirzepatide as low as $177/month, flat across doses. For a broader cost comparison, our GLP-1 Price Check directory covers GLP-1 pricing without insurance.
Full pricing landscape: GLP-1 telehealth price comparison.
Pros & Cons of Remedy Meds
Pros
- Unlimited clinician visits and messaging advertised
- Cancel-anytime service without a long-term contract
- Medication and necessary labs included in the base subscription
- Brand-name Ozempic and Zepbound also advertised
Cons
- Public pages reviewed here did not establish a product-specific dollar quote
- Automatic billing every 28 days, with a separate refill form
- Processed payments generally nonrefundable; initial ineligibility exception
- Dated September 2025 FDA marketing/misbranding letter
- Compounded medications are not FDA-approved
Remedy Meds Alternatives
SurpassMD is the useful comparison when a stated flat $114/$177 offer, oral semaglutide and nutrition guidance are priorities. Fridays is an option for 1:1 coaching and brand-name insurance help; Henry offers a distinct compounded oral tirzepatide program. Current quotes and billing periods determine the cost comparison. SurpassMD vs Remedy Meds and Fridays and Henry Meds and best GLP-1 telehealth providers
Best for: patients who value the advertised unlimited clinician visits and messaging. Compare alternatives if: a clearly stated public medication price or a different billing interval is the deciding factor. Remedy’s help page allows cancellation but separately limits refunds after payment, with an initial ineligibility exception.
Frequently Asked Questions
The current public Remedy pages reviewed October 28 did not establish a product-specific dollar quote. Its help center says billing renews every 28 days and covers medication, unlimited clinician visits and necessary lab work. The amount shown for the selected product and payment term governs.
The FDA’s September 9, 2025 letter cited misleading claims that implied the compounded products were the same as FDA-approved semaglutide or tirzepatide products. It identifies misbranding under the drug-labeling and promotion provisions. It is a marketing enforcement record, not a laboratory finding that every dispensed shipment was unsafe, and this review does not claim a current close-out determination.
Remedy’s help center describes no long-term contract and cancellation through the portal, but renewal occurs automatically every 28 days until canceled. Its refund page says processed payments are generally nonrefundable, with a full initial refund if the clinician determines the new patient is ineligible. A refill form is still needed before each shipment.
No current price ranking is established without a current Remedy quote. SurpassMD’s as-low-as flat offers are $114/month semaglutide and $177/month tirzepatide. Fridays, TrimRx and Henry publish different promotional, product and commitment offers; Remedy’s 28-day billing must also be aligned with any calendar-month comparison.
Its current help center says the base subscription covers medication, unlimited clinician visits and necessary lab work, stays the same when dosage changes, and can be canceled. The homepage advertises messaging, video access between check-ins and pharmacy fulfillment. These are supplier-described services rather than an independent test of access or shipping.
SurpassMD offers flat as-low-as $114/month semaglutide and $177/month tirzepatide, oral semaglutide, nutrition guidance and 48-hour cold dispatch. Fridays emphasizes coaching and brand-name insurance navigation. Henry advertises compounded oral tirzepatide, a different formulation from injections. TrimRx promotes dose-independent base plans with offer-specific discounts. Choose the service structure you need and compare quotes over the same billing period.
This page is informational and is not medical advice. Peptide Dossier and SurpassMD share ownership. We receive no referral fee or commission. Compounded medications are not FDA-approved. Pricing is subject to change.